Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples